Cargando…

Relations between recurrence risk perceptions and fear of cancer recurrence in breast cancer survivors

PURPOSE: This study aimed to: (1) determine the accuracy of Dutch breast cancer survivors’ estimations of the locoregional recurrence risk (LRR); (2) examine which variables influence (the accuracy of) risk estimations, and risk appraisals; and (3) investigate the influence of the objective LRR risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ankersmid, J. W., Lansink Rotgerink, F. K., Strobbe, L. J. A., van Uden-Kraan, C.F., Siesling, S., Drossaert, C. H. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Preclinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362565/ https://www.ncbi.nlm.nih.gov/pubmed/35907105 http://dx.doi.org/10.1007/s10549-022-06684-3

Ejemplares similares

Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty
por: Ankersmid, Jet W., et al.
Publicado: (2022)

Is de-escalation of treatment by omission of radiotherapy associated with fear of cancer recurrence in women with early breast cancer? An exploratory study
por: Stafford, Lesley, et al.
Publicado: (2023)

Follow‐up after breast cancer: Variations, best practices, and opportunities for improvement according to health care professionals
por: Ankersmid, Jet W., et al.
Publicado: (2021)

Recurrent read-through fusion transcripts in breast cancer
por: Varley, Katherine E., et al.
Publicado: (2014)

Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance
por: Ankersmid, Jet W., et al.
Publicado: (2022)

Health care professionals' perspectives on shared decision making supported by personalised‐risk‐for‐recurrences‐calculations regarding surveillance after breast cancer
por: Ankersmid, Jet W., et al.
Publicado: (2022)

Supporting Shared Decision-making About Surveillance After Breast Cancer With Personalized Recurrence Risk Calculations: Development of a Patient Decision Aid Using the International Patient Decision AIDS Standards Development Process in Combination With a Mixed Methods Design
por: Ankersmid, Jet Wies, et al.
Publicado: (2022)

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
por: Jansson, Sara, et al.
Publicado: (2018)

Adipose stem cell crosstalk with chemo-residual breast cancer cells: implications for tumor recurrence
por: Lyes, Matthew A., et al.
Publicado: (2018)

Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data
por: Orucevic, Amila, et al.
Publicado: (2017)

Fear of cancer recurrence in colorectal cancer survivors
por: Custers, José A. E., et al.
Publicado: (2015)

Symptom cluster of pain, fatigue, and psychological distress in breast cancer survivors: prevalence and characteristics
por: Bjerkeset, Ellen, et al.
Publicado: (2020)

Paired-like Homeodomain Transcription factor 2 expression by breast cancer bone marrow disseminated tumor cells is associated with early recurrent disease development
por: Pillai, Sreeraj G., et al.
Publicado: (2015)

Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis
por: Orucevic, Amila, et al.
Publicado: (2016)

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
por: Lips, E. H., et al.
Publicado: (2013)

Towards an evidence-based model of fear of cancer recurrence for breast cancer survivors
por: Custers, José A. E., et al.
Publicado: (2016)

Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study
por: Balmativola, D., et al.
Publicado: (2014)

Retrospective analysis of metastatic behaviour of breast cancer subtypes
por: Savci-Heijink, C. Dilara, et al.
Publicado: (2015)

Pan-cancer analysis of fear of cancer recurrence among cancer survivors
por: Adashek, J.J., et al.
Publicado: (2022)

The importance of early detection of calcifications associated with breast cancer in screening
por: Mordang, J. J., et al.
Publicado: (2017)

Study protocol for the evaluation of Fear-Less: a stepped-care program for fear of cancer recurrence in survivors with early-stage disease
por: Tran, Mei Jun, et al.
Publicado: (2022)

Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification
por: Kornegoor, Robert, et al.
Publicado: (2012)

Interpretation Bias in Breast Cancer Survivors Experiencing Fear of Cancer Recurrence
por: Tuman, Malwina, et al.
Publicado: (2021)

Enrichment of high-grade tumors in breast cancer gene expression studies
por: van Seijen, M., et al.
Publicado: (2017)

How common is fear of cancer recurrence in survivors and patients?
Publicado: (2022)

Genomic aberrations in normal tissue adjacent to HER2-amplified breast cancers: field cancerization or contaminating tumor cells?
por: Sadanandam, Anguraj, et al.
Publicado: (2012)

The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer
por: Eustace, A. J., et al.
Publicado: (2021)

Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer
por: Green, Andrew R., et al.
Publicado: (2016)

miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway
por: Lee, Jieun, et al.
Publicado: (2019)

Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach
por: Dekker, T. J. A., et al.
Publicado: (2015)

Individual courses and determinants of fear of cancer recurrence in long-term breast cancer survivors with and without recurrence
por: Heidkamp, Paula, et al.
Publicado: (2021)

HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer
por: Green, Andrew R., et al.
Publicado: (2014)

Natural history of age-related lobular involution and impact on breast cancer risk
por: Radisky, Derek C., et al.
Publicado: (2016)

Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile
por: Suelmann, B. B. M., et al.
Publicado: (2021)

Phenotypic characterisation of breast cancer: the role of CDC42
por: Chrysanthou, Eleni, et al.
Publicado: (2017)

Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort
por: Cheng, Angela S., et al.
Publicado: (2019)

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis
por: Engels, C. C., et al.
Publicado: (2015)

Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model
por: Ripoll, Giselle V., et al.
Publicado: (2013)

Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up
por: Yang, Sherry X., et al.
Publicado: (2019)

Biological and clinical significance of PARP1 protein expression in breast cancer
por: Green, Andrew R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3ap0sjidhoc0bodcmju20vm2ak